Ameriprise
WVE icon

Ameriprise’s Wave Life Sciences WVE Stock Holding History

Ameriprise’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-40,374
Closed -$293K – 4264
2026
Q1 		$293K Sell
40,374
-358,042
-90% -$4.66M ﹤0.01% 3767
2025
Q4 		$6.77M Buy
398,416
+290,551
+269% +$2.95M ﹤0.01% 2211
2025
Q3 		$790K Buy
+107,865
New +$873K ﹤0.01% 3467
2025
Q2 		– Sell
-10,830
Closed -$87.5K – 4145
2025
Q1 		$87.5K Buy
10,830
+416
+4% +$4.55K ﹤0.01% 3897
2024
Q4 		$129K Buy
+10,414
New +$139K ﹤0.01% 3924
2024
Q3 		– Sell
-25,994
Closed -$130K – 4024
2024
Q2 		$130K Sell
25,994
-350
-1% -$2K ﹤0.01% 3747
2024
Q1 		$163K Buy
26,344
+345
+1% +$1.73K ﹤0.01% 3716
2023
Q4 		$131K Buy
+25,999
New +$139K ﹤0.01% 3785
2018
Q2 		– Sell
-23,516
Closed -$943K – 3708
2018
Q1 		$943K Buy
+23,516
New +$989K ﹤0.01% 2992

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Ameriprise's WVE Position: Q2 2026 in Review

Ameriprise sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 40,374 shares — an estimated $293K sold.

Ameriprise first reported a position in WVE in Q1 2018 and held it in 9 quarters. The position peaked at $6.77M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Ameriprise reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Ameriprise sold 40,374 Wave Life Sciences shares in Q2 2026, an estimated $293K.
  • Ameriprise first reported a position in Wave Life Sciences in Q1 2018 and held it in 9 quarters.
  • Ameriprise's Wave Life Sciences position peaked at $6.77M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.